Unidoc Health Corp.
UDOCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 73.8% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 17.1% | 52.7% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $2 |
| Operating Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -248.4% | -506.2% | – | – |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -269.8% | -479.3% | – | – |
| EPS | -0.008 | -0.006 | -0.014 | -0.025 |
| % Growth | -33.9% | 56.6% | 42.6% | – |
| EPS Diluted | -0.008 | -0.006 | -0.014 | -0.025 |
| Weighted Avg Shares Out | 76 | 76 | 69 | 62 |
| Weighted Avg Shares Out Dil | 76 | 76 | 69 | 62 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$2 |
| % Margin | -255.2% | -445% | – | – |